U.S. Markets open in 36 hrs, 27 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 9.24 12:24 PM EST | |
|---|---|---|
| Day High | 9.71 10:03 AM EST |
|
| Range | 0.47 |
| Volume | 537,205 | |
|---|---|---|
| 30-Day Avg Vol | 836,000 |
|
| Difference | -35.74% |
| Market Cap | 823.62 M | |
|---|---|---|
| Mkt Cap Chg | -6.10 M |
| Shares Out | 87.15 M | |
|---|---|---|
| % Shrs Traded | 0.62% | |
| 1yr EPS Est | -1.043 |
| 52-Wk Low | 7.00 | |
|---|---|---|
| 52-Wk High | 14.94 |
|
| Range | 7.94 |
| Prev Close | 9.52 11/5/09 | |
|---|---|---|
| Today's Open | 9.44 | |
| Change | -0.84% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.16 M |
| Revenue (LFY) | 35.23 M | |
|---|---|---|
| Earnings (LFY) | -85.50 M | |
| Earnings (MRQ) | -19.83 M | |
| Next Earn Est | -0.244 | |
| Next Earnings | 02/05/2010 |
|
| EPS (TTM) | -1.17 | |
| 1yr EPS Growth | 11.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -9.00 | |
| PEG Ratio | — | |
| Return on Equity | -121.80 | |
| Beta | 1.22 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Seattle Genetics is working on monoclonal antibodies (MAbs) to treat a variety of cancers and autoimmune diseases. It is developing MAbs potent enough to fight cancer on their own, as well as those used ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.244 2/5/10 | — — |
—
—
|
| Last Quarter | -0.252 9/30/09 | -0.21 9/30/09 |
0.042
Beat
|
| 2 Quarters Ago | -0.29 6/30/09 | -0.26 6/30/09 |
0.03
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 11.65 M | 35.24 M |
| Gross Profit | 9.14 M | 31.82 M |
| Operating Income | -20.57 M | -91.79 M |
| Net Income | -19.83 M | -85.50 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts